Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147
- PMID: 19305422
- PMCID: PMC4002274
- DOI: 10.1038/aps.2009.21
Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147
Abstract
Aim: The aim of this study was to investigate the mechanism of the effects of Sinomenine (SIN) on the invasion and migration ability of activated human monocytic THP-1 cells (A-THP-1). Sinomenine is a pure alkaloid extracted from the Chinese medical plant Sinomenium acutum.
Methods: Human monocytic THP-1 cells were induced to differentiate into macrophages with phorbol 12-myristate 13-acetate (PMA). Cells were treated with different concentrations of SIN. The invasion and migration ability of cells was tested by in vitro transwell assays. The levels of CD147 and MMPs were evaluated by flow cytometric analysis and zymographic analysis, respectively. The mRNA expression of CD147, MMP-2, and MMP-9 was measured by RT-PCR.
Results: The invasion and migration ability of A-THP-1 cells was significantly inhibited by SIN in a concentration-dependent fashion; at the same time, the levels of CD147, MMP-2, and MMP-9 were markedly down-regulated. This inhibitory effect was most notable at concentrations of 0.25 mmol/L and 1.00 mmol/L (P<0.01).
Conclusion: A possible mechanism of the inhibitory effect of SIN on cell invasion and migration ability is repression of the expression of MMP-2 and MMP-9, which strongly correlates with the inhibition of CD147 activity.
Figures





Similar articles
-
Towards Better Sinomenine-Type Drugs to Treat Rheumatoid Arthritis: Molecular Mechanisms and Structural Modification.Molecules. 2022 Dec 7;27(24):8645. doi: 10.3390/molecules27248645. Molecules. 2022. PMID: 36557779 Free PMC article. Review.
-
Sinomenine reduces invasion and migration ability in fibroblast-like synoviocytes cells co-cultured with activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, CD147.Rheumatol Int. 2011 Nov;31(11):1479-85. doi: 10.1007/s00296-010-1506-2. Epub 2010 May 16. Rheumatol Int. 2011. PMID: 20473759
-
Inhibiting effects of Leflunomide metabolite on overexpression of CD147, MMP-2 and MMP-9 in PMA differentiated THP-1 cells.Eur J Pharmacol. 2011 Nov 16;670(1):304-10. doi: 10.1016/j.ejphar.2011.07.045. Epub 2011 Aug 19. Eur J Pharmacol. 2011. PMID: 21871883
-
Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis.Rheumatology (Oxford). 2008 Sep;47(9):1299-310. doi: 10.1093/rheumatology/ken225. Epub 2008 Jun 21. Rheumatology (Oxford). 2008. PMID: 18567920 Free PMC article.
-
A review on pharmacokinetics of sinomenine and its anti-inflammatory and immunomodulatory effects.Int Immunopharmacol. 2023 Jun;119:110227. doi: 10.1016/j.intimp.2023.110227. Epub 2023 Apr 27. Int Immunopharmacol. 2023. PMID: 37119677 Review.
Cited by
-
Sinomenine regulates immune cell subsets: Potential neuro-immune intervene for precise treatment of chronic pain.Front Cell Dev Biol. 2022 Dec 22;10:1041006. doi: 10.3389/fcell.2022.1041006. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36619869 Free PMC article. Review.
-
VEGF may contribute to macrophage recruitment and M2 polarization in the decidua.PLoS One. 2018 Jan 11;13(1):e0191040. doi: 10.1371/journal.pone.0191040. eCollection 2018. PLoS One. 2018. PMID: 29324807 Free PMC article.
-
Bioactivities and Mechanisms of Action of Sinomenine and Its Derivatives: A Comprehensive Review.Molecules. 2024 Jan 22;29(2):540. doi: 10.3390/molecules29020540. Molecules. 2024. PMID: 38276618 Free PMC article. Review.
-
Sinomenine alleviates gouty inflammation by inhibiting macrophage M1 polarization and neutrophil extracellular trap formation.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 17. doi: 10.1007/s00210-025-04161-4. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40381009
-
Towards Better Sinomenine-Type Drugs to Treat Rheumatoid Arthritis: Molecular Mechanisms and Structural Modification.Molecules. 2022 Dec 7;27(24):8645. doi: 10.3390/molecules27248645. Molecules. 2022. PMID: 36557779 Free PMC article. Review.
References
-
- Zhou H, Wong YF, Wang J, Cai X, Liu L. Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats. Biochem Biophys Res Commun. 2008;376:352–7. - PubMed
-
- Hua H, Chen X.Mechanistic study of sinomenine on analgesic and anti-inflammatory actions J Xi-an Med Univ 19894346–9.Chinese.
-
- Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol. 1996;18:529–43. - PubMed
-
- Li L, Zhang CL, Song BW.Research of the pharmacological effect of sinomenine and clinical application Tradit Chin Drug Res Clin Pharmacol 2006717–4.Chinese.
-
- Li XJ, Yue PY, Ha WY, Wong DY, Tin MM, Wang PX, et al. Effect of sinomenine on gene expression of the IL-1β-activated human synovial sarcoma. Life Sci. 2006;79:665–73. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous